DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMII) Operating income
DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMII) annual operating income history from SEC filings — each fiscal year as reported.
-$488,385FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$488,385 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMII financial trends
DMII RevenueDMII Net incomeDMII Net marginDMII Gross profitDMII Gross marginDMII Operating marginDMII Operating cash flowDMII Free cash flowDMII Capital expendituresDMII Return on equityDMII Stock buybacksDMII Dividends paidDMII Total assetsDMII Total liabilitiesDMII Shareholders’ equityDMII overview →